Zymeworks Inc Asset Turnover Ratio (ZYME), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Zymeworks Inc   (NASDAQ: ZYME)
 

Zymeworks Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Zymeworks Inc 's asset turnover ratio, the ratio that measures the ability of Zymeworks Inc 's assets to generate revenue, sequentially decreased to 0.09 in the second quarter (Jun 30 2026), which does not come as a surprise, as the Zymeworks Inc continue to experience difficult business climate.

Within sector 160 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the II Quarter 2026, to 2852, from total ranking in the first quarter 2026 at 3067.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ZYME Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change -2.45 % 12.38 % -22.08 % -15.03 % -17.74 %
Y / Y Revenue Change -90.58 % -91.12 % -91.9 % 72.59 % 153.21 %
Asset Turnover Ratio (TTM) 0.09 0.2 0.27 0.32 0.28
ZYME's Total Ranking # 2852 # 3067 # 2616 # 2799 # 3075
Seq. Asset Change -16.7 % 38 % -12.77 % -2.72 % -4.03 %
Seq. Revenue Change 90.61 % -4.25 % -90.89 % -43.33 % 79.73 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 161
Healthcare Sector # 481
Overall Market # 2852

Asset Turnover Ratio Statistics
High Average Low
0.94 0.23 0.04
(Dec 31 2022)   (Jun 30 2021)




ZYME Company Profile • Back to ZYME Efficiency Comparisons • Compare ZYME Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Siga Technologies Inc  0.25 $ 53.659  Millions$ 211.549  Millions
Biolife Solutions Inc   0.25 $ 102.718  Millions$ 411.591  Millions
Plus Therapeutics Inc   0.24 $ 4.203  Millions$ 17.235  Millions
Cryoport inc   0.24 $ 186.452  Millions$ 764.783  Millions
Editas Medicine Inc   0.24 $ 47.005  Millions$ 193.747  Millions
Revvity Inc  0.24 $ 2,911.811  Millions$ 12,087.447  Millions
Elutia Inc   0.24 $ 11.353  Millions$ 47.654  Millions
Retractable Technologies Inc  0.24 $ 33.488  Millions$ 142.089  Millions
Alpha Cognition Inc.  0.23 $ 15.261  Millions$ 64.950  Millions
Bio Green Med Solution Inc   0.23 $ 1.861  Millions$ 7.940  Millions
Teleflex Incorporated  0.23 $ 1,628.534  Millions$ 7,097.240  Millions
Personalis Inc   0.23 $ 69.669  Millions$ 303.633  Millions
Petvivo Holdings Inc   0.23 $ 1.182  Millions$ 5.211  Millions
Theravance Biopharma inc   0.23 $ 104.311  Millions$ 460.778  Millions
Biocorrx Inc   0.23 $ 0.787  Millions$ 3.478  Millions
Sutro Biopharma Inc   0.22 $ 45.702  Millions$ 204.985  Millions
Enanta Pharmaceuticals Inc  0.22 $ 65.258  Millions$ 293.260  Millions
Nutriband Inc   0.22 $ 1.618  Millions$ 7.288  Millions
Cannapharmarx Inc   0.21 $ 1.699  Millions$ 8.027  Millions
Autolus Therapeutics Plc  0.21 $ 117.390  Millions$ 567.827  Millions
Beyond Air Inc   0.21 $ 6.677  Millions$ 32.326  Millions
Pacific Biosciences Of California Inc   0.20 $ 159.315  Millions$ 780.364  Millions
Ideaya Biosciences Inc   0.20 $ 234.127  Millions$ 1,158.627  Millions
Dariohealth Corp   0.20 $ 21.196  Millions$ 106.918  Millions
Safe Pro Group Inc   0.20 $ 2.881  Millions$ 14.769  Millions
60 Degrees Pharmaceuticals Inc   0.19 $ 1.111  Millions$ 5.775  Millions
Moderna Inc   0.19 $ 2,228.000  Millions$ 11,730.500  Millions
4d Molecular Therapeutics Inc   0.18 $ 92.008  Millions$ 499.053  Millions
Nrx Pharmaceuticals Inc   0.18 $ 3.394  Millions$ 18.504  Millions
Lexicon Pharmaceuticals Inc   0.18 $ 41.469  Millions$ 227.448  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.